Unchained Labs
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$25.0m | Series A | ||
$25.0m | Series B | ||
$13.0m | Series C | ||
$17.0m | Series D | ||
$50.0m | Debt | ||
$435m Valuation: $435m | Acquisition | ||
* | $155m | Debt | |
Total Funding | $80.0m |
Recent News about Unchained Labs
EditUnchained Labs is a life sciences company that specializes in providing innovative tools and technologies designed to address complex research and development challenges. The company serves scientists and researchers in the life sciences sector, offering solutions that enhance the efficiency and accuracy of their work. Operating in the global life sciences market, Unchained Labs focuses on developing automated instrumentation and consumables that streamline workflows and improve the precision of protein quantification and other critical research tasks. The business model revolves around the sale of high-tech instruments and consumables, as well as providing ongoing support and services to ensure optimal performance and customer satisfaction. Revenue is generated through direct sales, service contracts, and consumable sales, catering primarily to pharmaceutical companies, biotech firms, and academic research institutions.
Keywords: life sciences, protein quantification, automated workflows, research tools, biotech, pharmaceutical, consumables, instrumentation, R&D, precision.